脾硬度测定排除无肝硬化慢性门静脉血栓患者的高危静脉曲张
本研究在16个VALDIG中心回顾性纳入无肝硬化的慢性门静脉血栓患者,评估脾硬度测定(SSM-VCTE)排除高危静脉曲张(HRV)的性能。推导队列159例(43%有HRV),验证队列187例(32%有HRV)。SSM-VCTE≤40 kPa在推导队列灵敏度97%、阴性预测值97%、可避免41%内镜、漏诊3% HRV;验证队列可避免43%内镜、漏诊5% HRV、阴性预测值96%。
要点
- 无肝硬化慢性门静脉血栓患者中,SSM-VCTE≤40 kPa可识别HRV低风险者。
- SSM-VCTE≤40 kPa约可避免40%的筛查内镜,漏诊HRV≤5%。
- 肝硬化来源的肝硬度切点不适用于无肝硬化慢性门静脉血栓人群。
核心结论
- 在无肝硬化的慢性门静脉血栓患者中,SSM-VCTE≤40 kPa可识别高危静脉曲张低风险患者,使约40%患者免于筛查内镜,漏诊HRV≤5%。
研究设计与样本
- 回顾性纳入16个VALDIG中心无肝硬化慢性门静脉血栓患者,内镜在SSM-VCTE前后2年内完成。
- 患者分为推导队列159例和验证队列187例。
主要发现
- 推导队列43%有HRV,验证队列32%有HRV。
- 单变量分析中,骨髓增殖性肿瘤、腹水、血红蛋白、胆红素、白蛋白、脾大、门体侧支、LSPS、肝硬度测定和SSM-VCTE在两个队列均与HRV相关。
- 多变量二元logistic回归分析中,仅SSM-VCTE(p<0.005)在两个队列均与HRV相关。
- 推导队列SSM-VCTE≤40 kPa排除HRV的灵敏度97%,可避免41%内镜,漏诊3% HRV,阴性预测值97%。
- 验证队列SSM-VCTE≤40 kPa可避免43%内镜,漏诊5% HRV,阴性预测值96%。
关键数值与推荐
- SSM-VCTE≤40 kPa用于排除HRV:推导队列灵敏度97%、阴性预测值97%、避免41%内镜、漏诊3% HRV。
- 验证队列SSM-VCTE≤40 kPa避免43%内镜、漏诊5% HRV、阴性预测值96%。
临床怎么用
- 对无肝硬化慢性门静脉血栓患者,可用SSM-VCTE≤40 kPa识别HRV低风险者,免于筛查内镜。
- 每年监测脾硬度可能减少终生重复筛查内镜的需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Screening endoscopy can be spared in patients with compensated cirrhosis when spleen stiffness measurement (SSM) by vibration-controlled transient elastography (VCTE) is ≤40 kPa, as these patients have a low probability of high-risk varices (HRV). Conversely, endoscopy is required in all patients with chronic portal vein thrombosis (PVT) without cirrhosis. The objective was to evaluate the performance of SSM-VCTE for excluding HRV in patients with chronic PVT. METHODS: We retrospectively included patients with chronic PVT without cirrhosis who underwent upper endoscopy within 2 years before or after SSM-VCTE at 16 VALDIG centres. Patients were divided into derivation and validation cohorts. RESULTS: A total of 159 patients were included in the derivation cohort; 43% had HRV. A total of 187 patients were included in the validation cohort; 32% had HRV. On univariable analysis, myeloproliferative neoplasm, ascites, hemoglobin, bilirubin, albumin, splenomegaly, portosystemic collaterals, liver stiffness-spleen diameter-to-platelet ratio score, liver stiffness measurement and SSM-VCTE were associated with HRV in both cohorts. On multivariable binary logistic regression analysis, only SSM-VCTE (p <0.005) remained associated with HRV in both cohorts. In the derivation cohort, SSM-VCTE ≤ 40 kPa had a sensitivity of 97% to rule out HRV, and could spare 41% of endoscopies, with 3% of HRV missed, and a 97% negative predictive value (NPV). In the validation cohort, SSM-VCTE ≤40 kPa could spare 43% of endoscopies, with 5% of HRV missed, and a 96% NPV. CONCLUSIONS: In this study of 346 patients with chronic PVT without cirrhosis, SSM-VCTE ≤40 kPa identified patients at low risk of HRV, allowing endoscopy to be spared in approximately 40% of patients while missing ≤5% of HRV. IMPACT AND IMPLICATIONS: Patients with chronic portal vein thrombosis who do not have cirrhosis usually have low liver stiffness measurement values; the liver stiffness cut-offs used to rule out high-risk varices in patients with cirrhosis cannot therefore be used in this population. We show here that spleen stiffness measurement by vibration-controlled transient elastography ≤40 kPa is able to identify patients with chronic portal vein thrombosis with a very low probability of high-risk varices, in whom screening endoscopy can be spared. Annual surveillance of spleen stiffness measurement could reduce the need for repeated screening endoscopies throughout a person's lifetime. This approach could enhance quality of life while also reducing risks associated with endoscopic procedures, particularly those related to anesthesia.
引用
- Moga L, Payancé A, Téllez L, et al. Spleen stiffness measurement rules out high-risk varices in patients with chronic portal vein thrombosis without cirrhosis. J Hepatol. 2026. PMID: 42679862. doi:10.1016/j.jhep.2026.08.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。